These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9556686)

  • 21. Breast cancer risk factors. The latest facts, your best means of defense.
    Mayo Clin Womens Healthsource; 2007 Oct; 11(10):1-2. PubMed ID: 18418906
    [No Abstract]   [Full Text] [Related]  

  • 22. Does raloxifene reduce breast cancer risk?
    Mattimoe D; Newton W
    J Fam Pract; 1999 Sep; 48(9):659-60. PubMed ID: 10498063
    [No Abstract]   [Full Text] [Related]  

  • 23. [Review of risk factors for breast cancer--what's new?].
    Haimov-Kochman R; Lavy Y; Hochner-Celinkier D
    Harefuah; 2002 Aug; 141(8):702-8, 761. PubMed ID: 12222134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing breast cancer with tamoxifen.
    Health News; 1998 May; 4(6):1, 5. PubMed ID: 9602560
    [No Abstract]   [Full Text] [Related]  

  • 25. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
    Vogel VG
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.
    Labrie F
    Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):584-93. PubMed ID: 17643129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunities for research on prevention of breast cancer.
    Henderson M
    Cancer Prev Control; 1997 Jun; 1(2):133-7. PubMed ID: 9765735
    [No Abstract]   [Full Text] [Related]  

  • 28. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 9 facts everyone should know about breast cancer.
    Baron RH; Walsh A
    Am J Nurs; 1995 Jul; 95(7):29-33. PubMed ID: 7604861
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
    Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
    J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing "unpreventable" cancers.
    Harv Womens Health Watch; 1999 Nov; 7(3):1. PubMed ID: 10521915
    [No Abstract]   [Full Text] [Related]  

  • 32. Perspectives and progress in development of breast cancer chemopreventive drugs.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk ET; Steele VE; Lubet RA; Sigman CC
    Prog Clin Biol Res; 1997; 396():159-83. PubMed ID: 9108597
    [No Abstract]   [Full Text] [Related]  

  • 33. The breast cancer prevention trial. Should Women at risk take tamoxifen?
    McKeon VA
    AWHONN Lifelines; 1998 Oct; 2(5):20-5. PubMed ID: 9919083
    [No Abstract]   [Full Text] [Related]  

  • 34. Postmenopausal HRT--a role for tamoxifen?
    Jackson G
    Int J Clin Pract; 1997; 51(5):267. PubMed ID: 9489081
    [No Abstract]   [Full Text] [Related]  

  • 35. Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.
    Cobleigh MA; Berris RF; Bush T; Davidson NE; Robert NJ; Sparano JA; Tormey DC; Wood WC
    JAMA; 1994 Aug; 272(7):540-5. PubMed ID: 8046809
    [No Abstract]   [Full Text] [Related]  

  • 36. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics.
    McPherson K; Steel CM; Dixon JM
    BMJ; 2000 Sep; 321(7261):624-8. PubMed ID: 10977847
    [No Abstract]   [Full Text] [Related]  

  • 37. [Breast carcinogenesis and sex hormones].
    Sato B
    Nihon Rinsho; 2000 Apr; 58 Suppl():19-24. PubMed ID: 11025968
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hormone and breast cancer].
    Gompel A
    Presse Med; 2019 Oct; 48(10):1085-1091. PubMed ID: 31662219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical reduction of breast cancer risk.
    Simmons S
    Nurse Pract; 2010 Sep; 35(9):10-1. PubMed ID: 20720461
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of women at high risk of breast cancer: an epidemiological view.
    Rohan TE
    Aust Fam Physician; 1982 Dec; 11(12):959-63. PubMed ID: 7159286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.